Cointime

Nalagenetics

company

About

Nalagenetics is a biotechnology company that provides genetic testing services.

  • 11 - 50

Highlights

Total Funding Amount
$12.60M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Non-Equity Assistant
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Nalagenetics is a health-tech company that provides genetic testing. In 2016, the company collaborated with the Indonesian health ministry to distribute 1,000 genetic test kits in five villages in Papua and West Papua. The company's tests revealed that 20% of leprosy patients in the area carry the gene responsible for potentially fatal reactions to Dapsone, an anti-leprosy medication; this discovery assisted doctors in determining which patients could be safely treated with the antibiotic.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$12.60M
Nalagenetics has raised a total of $12.60M in funding over 2 rounds. Their latest funding was raised on Aug 1, 2022 from a Non-Equity Assistant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 1, 2022 Non-Equity Assistant — 1 Google for Startups — Detail
Mar 25, 2022 Series A $12.60M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Nalagenetics is funded by 2 investors. Google for Startups and Diagnos Laboratories are the most recent investors.
Investor Name Lead Investor Funding Round
Google for Startups Yes Non-Equity Assistant
Diagnos Laboratories — Series A
Cointime
เนื้อหา
บริษัท